Mostrar el registro sencillo del ítem
Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma
dc.contributor.advisor | Arango Molano, Lázaro Antonio | |
dc.contributor.author | Bautista Parada, Ileana Rocio | |
dc.contributor.author | Arango Molano, Lázaro Antonio | |
dc.date.accessioned | 2022-02-11T00:04:37Z | |
dc.date.available | 2022-02-11T00:04:37Z | |
dc.date.issued | 2022-01-05 | |
dc.identifier.uri | https://repositorio.ucaldas.edu.co/handle/ucaldas/17396 | |
dc.description.abstract | spa:El cáncer de esófago es el octavo tipo de cáncer más frecuente en el mundo y el sexto causa de muerte por cáncer, con distribuciones variables según zonas geográficas región. Iniciativas para la detección precoz, tratamiento, control y seguimiento de diferentes patologías ha demostrado un impacto significativo en la reducción de la morbilidad y la mortalidad en diferentes patologías, aunque no existen protocolos establecidos para el esófago tamizaje de cáncer en población general, factores de riesgo asociados al desarrollo de esta condición están bien definidos, y esto permite identificar y priorizar la población con mayor riesgo. | spa |
dc.description.abstract | eng:Esophageal cancer is the 8th most frequent type of cancer in the world and the 6th cause of death from cancer, with variable distributions according to geographic region, it ́s mortality rate remains high because is rarely diagnosed at early stages. It has been reported that nearly 40% of patients have metastasized at the time of diagnosis; this added to the special anatomical conditions of the mediastinum and the high recurrence rate, confers it a worse prognosis and 5-year survival rate close to 20%. Initiatives for early detection, treatment, control and monitoring of different pathologies has shown a significant impact on reduction of morbidity and mortality in different pathologies, although there are no established protocols for esophageal cancer screening in general population, risks factors associated with development of this condition are well defined, and this allows identify and prioritize population with highest risk | eng |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | eng | spa |
dc.language.iso | spa | spa |
dc.title | Risk Factors and Screening Strategies for Early Detection of Esophageal Carcinoma | eng |
dc.type | Artículo de revista | spa |
dc.description.degreelevel | Especialización | spa |
dc.identifier.instname | Universidad de Caldas | spa |
dc.identifier.reponame | Repositorio institucional Universidad de Caldas | spa |
dc.identifier.repourl | https://repositorio.ucaldas.edu.co/ | spa |
dc.publisher.faculty | Facultad de Ciencias Para la Salud | spa |
dc.publisher.place | Manizales | spa |
dc.relation.references | 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. | spa |
dc.relation.references | 2. Zakko, L; Lutzke, L; Wang K. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am. 2017;26(2):163–78. | spa |
dc.relation.references | 3. Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res. 2016;113:236–44. | spa |
dc.relation.references | 4. Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76(4):1367–9. | spa |
dc.relation.references | 5. Njei B, Mccarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–6. | spa |
dc.relation.references | 6. Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol [Internet]. 2020;13(6):1010–21. | spa |
dc.relation.references | 7. Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology [Internet]. 2018;154(2):390–405. Available from: https://doi.org/10.1053/j.gastro.2017.07.046 | spa |
dc.relation.references | 8. Chen T, Cheng H, Chen X, Yuan Z, Yang X, Zhuang M, et al. Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma. Sci Rep [Internet]. 2015;5(July):1–9. | spa |
dc.relation.references | 9. Turati F, Negri E, Vecchia C La. Family history and the risk of cancer: genetic factors influencing multiple cancer sites. Expert Rev Anticancer Ther. 2014;14(1):1–4. | spa |
dc.relation.references | 10. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the international BEACON consortium. Int J Epidemiol. 2012;41(6):1706–18. | spa |
dc.relation.references | 11. Choi YJ, Lee DH, Han K Do, Kim HS, Yoon H, Shin CM, et al. Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea (PLoS ONE (2017) 12:10 (e0185778) DOI: 10.1371/journal.pone.0185778). PLoS One. 2018;13(5):1–13. | spa |
dc.relation.references | 12. Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions. J Nutr. 2020;150(4):663–71. | spa |
dc.relation.references | 13. Cook MB, Thrift AP. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am [Internet]. 2021;31(1):1–26. | spa |
dc.relation.references | 14. Kate Shannon . GODPJSJMCFRN. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2015;44(2):203–31. | spa |
dc.relation.references | 15. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol [Internet]. 2016;111(1):30–50. | spa |
dc.relation.references | 16. Mohy-ud-din N, Krill TS, Shah AR, Chatila AT, Singh S, Bilal M, et al. Barrett’s esophagus: What do we need to know? Disease-a-Month. 2020;66(1):1–12 | spa |
dc.relation.references | 17. AmaDi C Di, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol. 2017;23(28):5051–67 | spa |
dc.relation.references | 18. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol. 2000;95(11):3089–96 | spa |
dc.relation.references | 19. Naini B V., Chak A, Ali MA, Odze RD. Barrett’s oesophagus diagnostic criteria: Endoscopy and histology. Best Pract Res Clin Gastroenterol [Internet]. 2015;29(1):77–96. | spa |
dc.relation.references | 20. Horvath B, Singh P, Xie H, Thota PN, Allende DS, Pai RK, et al. Risk for esophageal neoplasia in Barrett’s esophagus patients with mucosal changes indefinite for dysplasia. J Gastroenterol Hepatol. 2015;30(2):262–7 | spa |
dc.relation.references | 21. Sharma P, Shaheen NJ, Katzka D, Bergman JJGHM. AGA Clinical Practice Update on Endoscopic Treatment of Barrett’s Esophagus With Dysplasia and/or Early Cancer: Expert Review. Gastroenterology [Internet]. 2020;158(3):760–9 | spa |
dc.relation.references | 22. Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42. | spa |
dc.relation.references | 23. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol [Internet]. 2012;9(5):278–87 | spa |
dc.relation.references | 24. Yang J, Wei WQ, Niu J, Liu ZC, Yang CX, Qiao YL. Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. World J Gastroenterol. 2012;18(20):2493–501. | spa |
dc.relation.references | 25. Spataro J, Zfass AM, Schubert M, Shah T. Early Esophageal Cancer: A Gastroenterologist’s Disease. Dig Dis Sci [Internet]. 2019;64(11):3048–58. | spa |
dc.relation.references | 26. Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg [Internet]. 2015;99(6):1879–86 | spa |
dc.relation.references | 27. Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20(9). | spa |
dc.relation.references | 28. Kim JA, Shah PM. Screening and prevention strategies and endoscopic management of early esophageal cancer. Chinese Clin Oncol. 2017;6(5):1– 11. | spa |
dc.relation.references | 29. Sun F, Yuan P, Chen T, Hu J. Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: A systematic review and meta-analysis. J Cardiothorac Surg. 2014;9(1). | spa |
dc.relation.references | 30. Halpern AL, McCarter MD. Palliative Management of Gastric and Esophageal Cancer. Surg Clin North Am [Internet]. 2019;99(3):555–69. | spa |
dc.relation.references | 31. Kim JY, Kim SG, Lim JH, Im JP, Kim JS, Jung HC. Clinical outcomes of esophageal stents in patients with malignant esophageal obstruction according to palliative additional treatment. J Dig Dis. 2015;16(10):575–84. | spa |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | spa |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | spa |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | spa |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | spa |
dc.subject.lemb | Cáncer | |
dc.subject.lemb | Esófago-enfermedades | |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/bachelorThesis | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/TP | spa |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
oaire.version | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
oaire.accessrights | http://purl.org/coar/access_right/c_14cb | spa |
dc.description.degreename | Especialilista en Gastroenterología Clínico Quirúrgica | spa |
dc.publisher.program | Especialización Gastroenterología Clínico Quirúrgica | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_14cb | spa |